Related News
China negotiates on patented, imported drugs, prices to halve
Online Edition
THE National Health and Family Planning Commission is negotiating with pharmaceutical companies on lowering prices of five drugs as part of a pilot program, said Li Bin, head of the commission, on Tuesday.
The five drugs are for treatment of cancer or other major diseases, and are very expensive as they are patented or imported, Li said, adding that their prices are expected to be cut by at least half.
Li, who was speaking at the press conference on the sidelines of the annual parliamentary session, did not elaborate on which drugs or pharmaceutical companies are involved.
Once negotiations are concluded successfully, the drugs can be covered by health insurance, added Ma Xiaowei, the commission's deputy.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
